Literature DB >> 24401828

Evaluation of intrarater and interrater reliability of the Wisconsin Gait Scale with using the video taped stroke patients in a Turkish sample.

A Yaliman1, N Kesiktas1, M Ozkaya1, N Eskiyurt1, O Erkan1, E Yilmaz1.   

Abstract

OBJECTIVE: To establish the intrarater and interrater reliability of Wisconsin Gait Scale (WGS) in hemiplegic patients.
DESIGN: Repeated-measures reliability study using video data of stroke patients.
SETTING: Rehabilitation department of the university hospital. PARTICIPITANTS: Nineteen hemiplegic patients with 3-9 months stroke history and two physiatrists and two physical therapists.
INTERVENTIONS: Video recordings were assessed twice, at an interval of 2 days, by the two physiatrists and two physical therapists. MAIN OUTCOME MEASURE: Wisconsin Gait Scale.
RESULTS: Internal consistency coefficients for the WGS were excellent; Cronbach scores were 0.91 and 0.94 for the first and third days. Coefficient of Repeatability (CR) for observers' WGS assessments were ranged between 4.23-5.76 and intraclass correlation coefficients for total WGS score were indicated very high interrater reliability at the begining and end, respectively 0.91 and 0.96. Intraclass correlation coefficients for fourteen items of WGS ranged from 0.81 to 1. "Hip hiking at mid-swing", "Circumduction at mid-swing" and "Hip extension of the affected leg" were the items with lowest correlation coefficients. Intrarater reliability for total WGS scores ranged from 0.75 to 0.90.
CONCLUSION: WGS was found excellent in reliability and may provide an objective means to document the findings from observational gait analysis, which is frequently used in clinical practice by rehabilitation teams.

Entities:  

Keywords:  Gait; Wisconsin Gait Scale; reliability; stroke

Mesh:

Year:  2014        PMID: 24401828     DOI: 10.3233/NRE-131033

Source DB:  PubMed          Journal:  NeuroRehabilitation        ISSN: 1053-8135            Impact factor:   2.138


  7 in total

1.  The paediatric version of Wisconsin gait scale, adaptation for children with hemiplegic cerebral palsy: a prospective observational study.

Authors:  Agnieszka Guzik; Mariusz Drużbicki; Andrzej Kwolek; Grzegorz Przysada; Katarzyna Bazarnik-Mucha; Magdalena Szczepanik; Andżelina Wolan-Nieroda; Marek Sobolewski
Journal:  BMC Pediatr       Date:  2018-09-15       Impact factor: 2.125

2.  Assessment of Agreement Between a New Application to Compute the Wisconsin Gait Score and 3-Dimensional Gait Analysis, and Reliability of the Application in Stroke Patients.

Authors:  Agnieszka Guzik; Andżelina Wolan-Nieroda; Mariusz Drużbicki
Journal:  Front Hum Neurosci       Date:  2022-02-03       Impact factor: 3.169

3.  Spanish Cross-Cultural Adaptation of the Wisconsin Gait Scale.

Authors:  Cecilia Estrada-Barranco; Vanesa Abuín-Porras; Javier López-Ruiz; Ismael Sanz-Esteban; Francisco Molina-Rueda; Roberto Cano-de-la-Cuerda
Journal:  Int J Environ Res Public Health       Date:  2021-06-27       Impact factor: 3.390

4.  The reliability, validity and correlation of two observational gait scales assessed by video tape for Chinese subjects with hemiplegia.

Authors:  Xi Lu; Nan Hu; Siyu Deng; Jun Li; Shuyan Qi; Sheng Bi
Journal:  J Phys Ther Sci       Date:  2015-12-28

5.  Interrater and intrarater reliability and minimal detectable change of the Wisconsin Gait Scale when used to examine videotaped gait in individuals post-stroke.

Authors:  Robert Wellmon; Amy Degano; Joseph A Rubertone; Sandra Campbell; Kelly A Russo
Journal:  Arch Physiother       Date:  2015-10-05

6.  Can an Observational Gait Scale Produce a Result Consistent with Symmetry Indexes Obtained from 3-Dimensional Gait Analysis?: A Concurrent Validity Study.

Authors:  Agnieszka Guzik; Mariusz Drużbicki; Lidia Perenc; Justyna Podgórska-Bednarz
Journal:  J Clin Med       Date:  2020-03-28       Impact factor: 4.241

7.  Perceiving amputee gait from biological motion: kinematics cues and effect of experience level.

Authors:  I-Chieh Lee; Matheus M Pacheco; Michael D Lewek; He Huang
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.